Taken together, our findings demonstrate that betaine can improve obesity and associated MS via the gut microbiota-derived miR-378a/YY1 regulatory axis, and reveal a novel mechanism by which gut microbiota improve host health. This evidence concerns the gene YY1 and obesity due to melanocortin 4 receptor deficiency.